Cardiovascular pharmaceuticals Market in India 2014
- NET3245695
- 99 Pages
- June 2014
- Healthcare
Growing incidences of cardiovascular diseases is helping the Indian market to grow and large pharmaceutical companies are trying to launch new patented blockbuster drugs to tackle the situation. Patented blockbuster drugs, after becoming generic, present a huge opportunity for growth. Generic drugs increase the affordability among patients, which helps in the growth of the market. The increasing disposable income of people are also helping to boost the market size. Some challenges faced by the industry are the internal competition between large pharmaceutical companies and competition from complementary and alternative medicines. Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well
Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jun 2013 - Nov 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Oct 2013 - March 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)
Introduction
Slide 5: Major Drug Classes
Market Overview
Slide 6-7: Global Cardiovascular Pharmaceutical Market - Overview, Indian Cardiovascular Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e)
Value Chain
Slide 8-9: Market Value Chain Analysis
Drivers & Challenges
Slide 10: Drivers and Challenges - Summary
Slide 11-14: Drivers
Slide 15: Challenges
Government Initiatives
Slide 16: Government Initiatives - Summary
Slide 17: National List of Essential Medicines (NLEM), Jan Aushadhi Stores (JAS)
Slide 18: Various tax reforms and control programmes
Slide 19-20: Licensing and registration of pharmaceuticals
Slide 21: Various other regulatory frameworks
Slide 22: Patent Expiry - Cardiovascular Drugs
Competitive Landscape
Slide 23: Porter's Five Forces Analysis
Slide 24: Public Trading Comparables, Top 4 Companies
Slide 25-27: Competitive Benchmarking, Key Ratios of Top 3 Companies - Operational Basis (FY 2013)
Slide 28: Competitive Benchmarking, Key Ratios of Top 3 Companies - Financial Basis (FY 2013)
Slide 29-76: Major Public Players
Slide 77-95: Major Private Players
Recent Developments
Slide 96: Recent Developments
Strategic Recommendation
Slide 97: Strategies
Appendix
Slide 98: Key Ratios Description
Slide 99: Sources of Information
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
